Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Weiqida Pharmaceutical Co., Ltd. is a pharmaceutical manufacturing company based in Taizhou, China, and a key subsidiary of the state-owned China Meheco Group. The company specializes in the research, development, and large-scale production of finished pharmaceutical dosages, with a core focus on anti-infectives, particularly cephalosporins and penicillins. Operating within the China Medical City industrial hub, its facilities are designed to meet international GMP standards for oral solid dosages and other formulations. By integrating with the extensive API production capabilities of its sister companies under the Weiqida brand, Jiangsu Weiqida maintains a highly competitive position in the global antibiotic supply chain. The company also produces a range of cardiovascular and gastrointestinal medications, serving both the domestic Chinese market and international export regions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangsu Weiqida Pharmaceutical.